{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"selank-sciatica","urls":{"read":"https://miscsubjects.com/api/articles/selank-sciatica/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/selank-sciatica/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/selank-sciatica/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/selank-sciatica/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/selank-sciatica/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/selank-sciatica/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/selank-sciatica/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"selank-sciatica","title":"Selank for Sciatica: Targeting the Anxiety and Neurochemistry Layer of Nerve Compression","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:41:40.792Z","body_excerpt":"## What's breaking down if you have Sciatica\n\nSciatica is nerve pain along the sciatic nerve — often from disc herniation or stenosis compressing a root. The nerve is signaling damage or compression. Suppressing pain does not uncompress the nerve.\n\nBreakdown outpaces repair when chronic stress chemistry, poor blood flow to the injury site, stalled inflammation, or ongoing neuropathic signaling keep the loop going. Mechanical compression plus secondary neurochemical changes can prolong symptoms even after the initial insult.\n\n## Why Selank might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\n4. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\n5. This article centers **Selank**; see other sections for bpc-157, tb-500, ara-290 — different layers, same condition.\n\n## Why BPC-157 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\n\n## Why TB-500 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## Why ARA-290 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Nerve compression, small-fiber loss, neuropathic pain signaling without tissue repair.\n3. **What ARA-290 is studied to do:** Studied for nerve repair and small-fiber regeneration in neuropathy models.\n4. **Therefore for you:** If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.\n\n## How these fit together\n\nEach compound above targets a different degeneration layer. Together they are a **stack** — not five copies of the same mechanism.\n- **Selank** → anxiety / neurochemistry\n- **BPC-157** → structure / tissue\n- **TB-500** → inflammation clearance / repair-cell migration\n- **ARA-290** → nerve / innervation\n\nPrimary focus of this slug: **Selank**. Others are in scope because the same condition breaks down on multiple layers.\n\n## What the evidence actually shows\n\nHuman data on Selank is limited to anxiety and generalized anxiety disorder (GAD). One small Russian study (62 patients with GAD or neurasthenia) compared Selank to medazepam and found comparable anxiolytic effects without sedation or withdrawal (Zozulia et al., 2008). Another trial showed 40% rapid responders with anxiety score drops in 3 days and 60% gradual responders by day 14 (Syunyakov et al., 2012). No human trials test Selank specifically for sciatica or nerve compression pain.\n\nPreclinical work suggests Selank modulates GABA-A receptors and may have neuroprotective effects (Volkova et al., 2016). These remain mechanistic until larger human studies exist.\n\nBPC-157, TB-500, and ARA-290 have stronger preclinical signals for tissue or nerve repair in animal models of injury and neuropathy, with ARA-290 showing small human signals in sarcoidosis-related small fiber neuropathy (phase 2 pil","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c1","text":"Selank showed comparable anxiolytic effects to medazepam in a 62-patient Russian study of GAD/neurasthenia without sedation or withdrawal.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Direct human evidence for Selank's primary studied use; grounds the anxiety layer discussion for sciatica readers.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c2","text":"No published human trials test Selank for sciatica or nerve compression pain.","tier":"human","weight":0.8,"section":"What we do not know","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Clarifies evidence gap so readers understand Selank targets neurochemistry layer only via mechanistic extrapolation.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c3","text":"ARA-290 improved neuropathic symptoms in a phase 2 pilot for sarcoidosis small fiber neuropathy.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2"],"source_status":"sourced","why_material":"Highest-tier human signal among the stack for nerve-related pain; contrasts with Selank's anxiety-only human data.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s1","type":"pubmed","url":"https://www.sciencedirect.com/science/article/pii/S0924933812752811","title":"Rapid and slow response during treatment of generalized anxiety disorder with peptide anxiolytic selank","quote":"40% of patients were rapid responders (RR) ... 60% of patients responded gradually ... Clinically significant changes of mean HARS total score from 16.1[7.2] to 6.2[4.7] were achieved at Day 14","summary":"Small Russian trial on Selank in GAD showing variable response speed and anxiety score reductions.","claim_ids":["c1","c2"],"link_status":"http_403","quote_status":"unverified","hash":"453ef805bac161bb61c7512c442a08d208136cf789b0eda6e8cdcd5af51a68a2"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4365069/","title":"ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves the Clinical Signs of Neuropathy","quote":"The results of these studies show that ARA 290 prevents tissue injury, reduces inflammation and activates healing. In preclinical models of neuropathy, ARA ...","summary":"Review and pilot data on ARA-290 for neuropathic conditions including sarcoidosis SFN.","claim_ids":["c3"],"link_status":"ok","quote_status":"unverified","hash":"2a15feb56f57cfdaaf429cc1365b75d6bfdb14d02c40337268e5bede86f49e31"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s1","type":"pubmed","url":"https://www.sciencedirect.com/science/article/pii/S0924933812752811","title":"Rapid and slow response during treatment of generalized anxiety disorder with peptide anxiolytic selank","quote":"40% of patients were rapid responders (RR) ... 60% of patients responded gradually ... Clinically significant changes of mean HARS total score from 16.1[7.2] to 6.2[4.7] were achieved at Day 14","summary":"Small Russian trial on Selank in GAD showing variable response speed and anxiety score reductions.","claim_ids":["c1","c2"],"link_status":"http_403","quote_status":"unverified","hash":"453ef805bac161bb61c7512c442a08d208136cf789b0eda6e8cdcd5af51a68a2"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4365069/","title":"ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves the Clinical Signs of Neuropathy","quote":"The results of these studies show that ARA 290 prevents tissue injury, reduces inflammation and activates healing. In preclinical models of neuropathy, ARA ...","summary":"Review and pilot data on ARA-290 for neuropathic conditions including sarcoidosis SFN.","claim_ids":["c3"],"link_status":"ok","quote_status":"unverified","hash":"2a15feb56f57cfdaaf429cc1365b75d6bfdb14d02c40337268e5bede86f49e31"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"selank-sciatica","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":3,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":3,"claims_total":3,"sources":2,"anecdotal":0,"scientific":2,"user_reports":0,"questions":0,"evidence_ingests":0}}